Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
Trends in Applied Sciences Research
  Year: 2007 | Volume: 2 | Issue: 2 | Page No.: 132-138
DOI: 10.3923/tasr.2007.132.138
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Synaptamine (SG8839),™ An Amino-Acid Enkephalinase Inhibition Nutraceutical Improves Recovery of Alcoholics, A Subtype of Reward Deficiency Syndrome (RDS)
Kenneth Blum, Thomas J.H. Chen, B.W. Downs, Brian Meshkin, Seth H. Blum, Manuel Martinez Pons, Julie F. Mengucci, Roger L. Waite, Vanessa Arcuri, Michael Varshofsiky and Eric R. Braverman

Abstract:
The present research was conducted to test the hypothesis that manipulation of the reward neural circuitry by utilization of oral and intravenous amino-acid–enkephalinase therapy would improve both the emotional and behavioral symptomology of recovering 600 alcoholics in an open trial clinical study. Our findings suggest that the combination of both oral and intravenous administration of SG8839 significantly improved both the emotional and behavioral recovery of the alcoholic subjects when compared to pre and post administration scores, including reduction of craving (p<0.001), reduced depression (p<0.001), reduced anxiety (p<0.001), anger (p<0.001), fatigue (p<0.001), lack of energy (p<0.001) and crisis (p<0.001). Mean reductions for anxiety (53.8±10.2%), craving (76.3±3.1%), depression (61.0±6.3%), fatigue (76.9±3.1%) and crisis (53.8±5.5%) were all significantly greater than 50% (p<0.001). This is the first study combining both oral and intravenous solutions suggesting clinical improvement.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Interaction between Anxiolytic Effects of Testosterone and β-1 Adrenoceptors of Basolateral Amygdala
How to cite this article:

Kenneth Blum, Thomas J.H. Chen, B.W. Downs, Brian Meshkin, Seth H. Blum, Manuel Martinez Pons, Julie F. Mengucci, Roger L. Waite, Vanessa Arcuri, Michael Varshofsiky and Eric R. Braverman, 2007. Synaptamine (SG8839),™ An Amino-Acid Enkephalinase Inhibition Nutraceutical Improves Recovery of Alcoholics, A Subtype of Reward Deficiency Syndrome (RDS). Trends in Applied Sciences Research, 2: 132-138.

DOI: 10.3923/tasr.2007.132.138

URL: https://scialert.net/abstract/?doi=tasr.2007.132.138

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

       

       

Curve Bottom